Neomed Innovations
PE-backed Wilson Therapeutics in SEK 7.1bn trade sale
Alexion Pharmaceuticals announces a public cash offer to acquire Wilson for SEK 232 per share
B&M Gates and VCs hold $45.5m series-D for Arsanis
New funding will be used to focus efforts on a phase II study for the prevention of pneumonia
NeoMed launches brain tumour therapy fund
Brain Tumour Charity has provided ТЃ10m to the ТЃ60-80m vehicle in its role as cornerstone investor
Imperial Innovations leads £13.5m round for Precision Ocular
Consort Medical, NeoMed and Hovione Scientia also joined the funding round
NeoMed leads CHF 20m Genkyotex financing
VI Partners and BioMedInvest are co-investors
Neomed's fifth fund holds €92m final close
Fund closed on slightly less than its predecessor
Neomed and Defi back CHF 1.3m round for Diagnoplex
Neomed and Defi Gestion have taken part in a CHF 1.3m funding round for Diagnoplex SA, a Swiss developer of diagnostics for colon cancer.




